In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
New questions and answers from the EMA regarding Titanium Dioxide in Medicines

New questions and answers from the EMA regarding Titanium Dioxide in Medicines

by In2Pharma | Dec 2, 2022 | News

Europe A new questions and answers concerning titanium dioxide was published by the EMA. The Q&A, including five questions, gives guidance about the replacement or removal of titanium dioxide in medicines. Titanium dioxide (E 171) is commonly used in the...
Titanium dioxide (E171) no longer considered safe when used as a food additive

Titanium dioxide (E171) no longer considered safe when used as a food additive

by In2Pharma | Jun 2, 2021 | News

Europe Titanium dioxide (E 171) is currently authorized as a food additive in the EU according to Annex II of Regulation 1333/2008.   EFSA has updated its safety assessment of the food additive titanium dioxide (E...

Recent Posts

  • Webinar Full FMD implementation
  • Food Supplements
  • Code of conduct GMH and CGR tightens the rules  
  • Introduction to FAMHP portal – manufacturing inspections
  • RD export 19/01/2023 – mandatory application for export

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België